AGP Executive Report
Last update: 8 hours agoFDA Oversight: The FDA’s Pharmacy Compounding Advisory Committee meets July 23–24 to decide whether seven popular peptides (including BPC-157 and TB-500) can be compounded under federal rules, despite limited human safety and effectiveness data. Clean Energy R&D: India’s MNRE approved INR 436.93 crore to extend its Renewable Energy Research and Technology Development program (2026-27 to 2030-31), including support for indigenous perovskite solar pilot manufacturing and broader energy storage and solar/wind/bioenergy work. AI for Science: Zhejiang University unveiled the “Qiushi Engine,” an AI system meant to plan, run, and refine research autonomously on open-ended problems. Climate Shock: Scientists warn Australia’s Great Barrier Reef faces extreme bleaching and possible ecosystem collapse tied to a strong El Niño. EV Supply Chains: Sabic and Saudi EV brand CEER signed an MoU to co-develop advanced EV materials and processing, aiming to boost local content. Health Tech & Trials: PatientsLikeMe and Science 37 partnered to speed patient access to clinical trials, targeting faster enrollment and better retention. Nuclear Fuel Cycle: ASP Isotopes’ Quantum Leap Energy signed a research deal with Texas A&M to de-risk domestic uranium conversion to UF6. Defense Tech: Beta Technologies showed its pilotless hybrid-electric MV250 at Farnborough, touting long range and vertical takeoff/landing.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
